Curlim
Develops nanomedicine therapies for hereditary peripheral neuropathies, beginning with Charcot-Marie-Tooth disease type 1A
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Curlim
Curlim is a nanomedicine company developing CLM001, a nanodrug intended to treat Charcot-Marie-Tooth disease type 1A (CMT1A). The company reports preclinical studies in animal models and is pursuing clinical development.
Founded in 2024 as a spin-off from the University of Limoges, Curlim is based in Limoges, France. Its team includes three PhD scientists and a business executive.
Product: CLM001, a nanodrug candidate intended to treat Charcot-Marie-Tooth disease type 1A.
Jobs at Curlim
Leadership
- Alexis Desmoulière · Co-founder, Pre-clinical SupportSource: company website
- Franck Sturtz · Co-founder, Steering Committee ChairmanSource: company website
- Vincent Sol · Co-founder, CMC SupportSource: company website
- Laurent Richebourg · Co-founder, CEOSource: company website
- Frédéric Elustondo · CTOSource: company website
More biotech & pharma companies
Cynbiose
Preclinical research services using non-human primate models for biopharmaceutical and life sciences developersNew on EvolcCytoo
Muscle disease drug-discovery services and micropattern products for pharmaceutical, biotechnology and research organizationsNew on EvolcDarewin Evolution
AI-guided microalgae strain selection and improvement for producers in food, nutraceuticals, cosmetics and bioremediationYoung companyNew on EvolcDBV Technologies
Develops VIASKIN epicutaneous immunotherapy patches for patients with food allergies and other immunological diseasesNew on EvolcDeeplife
AI-driven cell digital twins and multi-omics analysis for pharmaceutical drug discovery and developmentNew on EvolcDepixus
Magnetic force spectroscopy instruments for researchers studying biomolecular interactions and drug discoveryNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
